Considering a molecular clinical viewpoint, Relafen 750 (Naproxen) exhibits particular behaviors. It functions primarily as a cyclooxygenase agent, largely inhibiting cyclooxygenase-2 (COX-2), an enzyme implicated in prostaglandin production . This specific inhibition leads to decreased inflammation and discomfort , delivering clinical benefits for